The “aggressiveness” of a tumor is a complex notion which involves clinical and pathological aspects like BRAF V600E mutational status, histological subtype, clinical tumor stage... We showed that the variations of microRNA expressions between PTC sample subtypes seemed mainly related to the BRAF V600E mutational status. This evidence concerns the gene BRAF and neoplasm.